iSRS 2025 to be hosted in Australia

The 2025 International Symposium on Radiopharmaceutical Sciences (iSRS) will be hosted in Australia.

The National Imaging Facility supported Australia’s bid to host the 26th bi-annual global event.

The announcement was made at the 2022 event last month in Nantes, France, where it was also revealed NIF UNSW Facility Fellow Dr Giancarlo Pascali will be the upcoming Chair.

Dr Pascali said the iSRS is the most important conference in the field of basic radiochemistry developments, often debuting significant radiopharmaceutical innovations which will be introduced to clinical practice in the coming years.

“The iSRS has always been focused on the scientific grounds of our discipline and featuring examples of clinical success. It covers all the areas of radiochemistry, from targetry to imaging, preclinical imaging, radiometals, and the 18F and 11C staples,” Dr Pascali said.

The event is known for its engagement with new generations of radiochemists, with lectures mainly delivered by PhD students and early career researchers.

“In the last few years, the SRS have established the “Think Tank” team, allowing young investigators to contribute directly to the Society and the iSRS events, and even contributed to the creation of philanthropic support through the ‘Hot Atom Fund’,” he said.

“Therefore, if you are an imaging scientist interested in being among the first to witness the most promising radiopharmaceutical discoveries, or to network with the top experts and companies in the field, or simply looking to add an expert post-Doc in your lab, it is not a bad idea to join the 600+ attendees of the iSRS series!”

Dr Pascali has been a member of the event’s host institution, the Society of Radiopharmaceutical Sciences (SRS), for nearly two decades, since his first iSRS (at the time known as ISRC) attendance in Sydney 2003 as an Italian PhD student.

“I have been a member of the SRS since then, actively participating with scientific contributions, and more recently being part of the Scientific committee for the eSRS in 2021 (virtual) and the coming event in Hawaii in 2023,” he said.

As Chair for the 2025 event, Dr Pascali will coordinate and drive the conference planning and delivery alongside Co-Chair Prof Michael Kassiou,the International Scientific Program Committee and the Local Arrangements Committee.

For more information about the Society of Radiopharmaceutical Sciences, visit srsweb.org.

Meet our new Fellows

Meet the newest members of Australia’s advanced imaging network.

Their expertise is vital in applying imaging technologies, processing and interpreting imaging data, and applying imaging to solve complex problems.

We’re proud to extend our welcome to, and introduce, the newest members of NIF’s Fellows network, joining our team of experts enabling Australian imaging science to unlock solutions to major challenges.

USyd/ANSTO Facility Fellow
SAHMRI Facility Fellow
Monash Facility Fellow
Macquarie Facility Fellow

NIF Molecular Imaging and Radiochemistry Showcase to be presented at ANZSNM

National Imaging Facility enables access to imaging capabilities across the country and will present a Molecular Imaging and Radiochemistry Showcase at ANZSNM 2022, featuring presentations from a range of research leaders from Australia’s advanced imaging network.

See the full ANZSNM program here.

Register to attend ANZSNM 2022.

National Imaging Facility: Molecular Imaging and Radiochemistry Showcase
Saturday 14 May 2022, 3:15pm – 4:15pm
Session Chair: Prof Wojtek Goscinski, CEO National Imaging Facility

TimeSpeakerTopic
3:15 – 3:20Professor Wojtek Goscinski

Chief Executive Officer
National Imaging Facility

Introduction to NIF Molecular Imaging and
Radiochemistry Showcase

3:20 – 3:30Professor Steven Meikle

Head of the Imaging Physics Laboratory, Brain and Mind Research Institute, University of Sydney

Total Body PET
3:30 – 3:40Associate Professor Roslyn Francis

Head of Department of Nuclear Medicine and WA PET Service, Sir Charles Gairdner Hospital, University of Western Australia

Radiochemistry activities in Western Australia
3:40 – 3:50Professor Gary Egan

Professor and Foundation Director, Monash Biomedical Imaging

Director, ARC Centre of Excellence for Integrative Brain Function

Australian Precision Medicine Enterprise
3:50 – 4:00Prof Kristofer Thurecht

Acting Deputy Director (Research Technologies) and Group Leader – Principal Research Fellow,

Centre for Advanced Imaging, University of Queensland

Affiliate Principal Research Fellow and Group Leader,

Australian Institute for Bioengineering and Nanotechnology

Alpha therapies and activities
4:00 – 4:10Dr John Bennett

Research Infrastructure Platform Leader – Biosciences,
ANSTO

ANSTO’s new NIF Alpha Radioisotopes and
Radiopharmaceuticals Facility

Open-Field PET

Understanding the molecular mechanisms that regulate behaviour, memory, and reward-based learning has challenged neuroscientists for decades. Until recently, research into these fundamental mechanisms in the brain has relied on invasive or confounding methodologies, limiting studies of neurological disorders that affect behaviour and learning, such as depression, age-related neurodegeneration, and addiction.

Read More

National Preclinical PET QA

The NIF Molecular Imaging & Radiochemistry (MIR) Theme is a group of NIF Fellows, Directors, and users of NIF facilities that focus on state-of-the-art radiochemistry and molecular imaging applications using PET, SPECT, and MRI.

Integrating preclinical PET systems into a national resource requires the development of defined QA programs to monitor and integrate the data from individual systems. Hence, the MIR Theme initiated a national quality assurance (QA) program for the NIF preclinical PET instruments.

Read More
Privacy Settings
Youtube
Vimeo
Google Maps